Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Spencer Health Solutions Raises Series D to Expand Pharmaceutical and Care Management Markets
Life Sciences Times
-
August 30, 2023
0
Venture Capital
Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics
Life Sciences Times
-
August 29, 2023
0
Venture Capital
Danaher to acquire Abcam for $24.00 per Share
Life Sciences Times
-
August 28, 2023
0
Venture Capital
Cybin to Acquire Small Pharma Inc.
Life Sciences Times
-
August 28, 2023
0
Venture Capital
Botanical Solution, Inc. Secures Additional $7 Million, Totaling Over $13 Million in Series A Funding
Life Sciences Times
-
August 24, 2023
0
Venture Capital
Thermo Fisher Scientific Completes Acquisition of CorEvitas
Life Sciences Times
-
August 15, 2023
0
Venture Capital
Kohlberg signs a definitive agreement to acquire majority stake in Worldwide Clinical Trials
Life Sciences Times
-
August 7, 2023
0
Venture Capital
Amber Bio Raises $26 Million Seed Financing Co-Led by Playground Global and Andreessen Horowitz to Advance New RNA-Based Gene Editing Platform
Life Sciences Times
-
August 3, 2023
0
Venture Capital
LightForce Orthodontics Secures $80 Million Series D Funding Led By Ally Bridge Group, Opens Second Digital Factory
Life Sciences Times
-
August 2, 2023
0
Venture Capital
SK Capital Partners Closes Catalyst Fund II at $800 Million
Life Sciences Times
-
August 2, 2023
0
Venture Capital
UroGen Announces $120 Million Private Placement of Ordinary Shares
Life Sciences Times
-
July 27, 2023
0
Venture Capital
Nexo Therapeutics Launches With $60 Million Series A Financing
Life Sciences Times
-
July 26, 2023
0
1
...
42
43
44
...
115
Page 43 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026